ENGLEMAN; Edgar

Patent Applications and Registrations

Patent applications and USPTO patent grants for ENGLEMAN; Edgar.The latest application filed is for "2-arylbenzimidazoles as ppargc1a activators for treating neurodegenerative diseases".

Company Profile

3.2.8

ENGLEMAN; Edgar - Redwood City CA
Engleman; Edgar - Atherton CA
Engleman, Edgar - Athenton CA
Engleman, Edgar - Palo Alto CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
2-arylbenzimidazoles As Ppargc1a Activators For Treating Neurodegenerative Diseases App 20210300877 - BANISTER; Samuel D. ; et al.	2021-09-30
2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative diseases Grant 11,111,217 - Banister , et al. September 7, 2	2021-09-07
2-arylbenzimidazoles As Ppargc1a Activators For Treating Neurodegenerative Diseases App 20210061769 - BANISTER; Samuel D. ; et al.	2021-03-04
2-arylbenzimidazoles as PPARGC1A activators for treating neurodegenerative diseases Grant 10,851,066 - Banister , et al. December 1, 2	2020-12-01
2-arylbenzimidazoles As Ppargc1a Activators For Treating Neurodegenerative Diseases App 20200299244 - BANISTER; Samuel D. ; et al.	2020-09-24
Use Of A Chemically-stabilized Chlorite Solution For Inhibiting An Antigen-specific Immune Response App 20120141514 - Kuehne; Friedrich-W. ; et al.	2012-06-07
Use Of A Chemically-stabilized Chlorite Solution For Inhibiting An Antigen-specific Immune Response App 20110076344 - KUEHNE; Friedrich-W. ; et al.	2011-03-31
Use Of A Chemically-stabilized Chlorite Solution For Inhibiting An Antigen-specific Immune Response App 20090004295 - KUEHNE; Friedrich W. ; et al.	2009-01-01
Use of a chemically stabilized chlorite solution for inhibiting an antigen-specific immune response App 20050129784 - Kuehne, Friedrich-W. ; et al.	2005-06-16
Combination therapy of gamma-interferon and B-cell specific antibodies App 20050058644 - Engleman, Edgar	2005-03-17

Company Registrations

SEC

0001227162

ENGLEMAN EDGAR

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.